The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genomic heterogeneity in primary breast cancer: Clinical implications.
Lucy Rebecca Connolly
No relevant relationships to disclose
Stian Knappskog
No relevant relationships to disclose
Christine Desmedt
No relevant relationships to disclose
David Wedge
No relevant relationships to disclose
Peter Van Loo
No relevant relationships to disclose
Moritz Gerstung
No relevant relationships to disclose
Aquila Fatima
No relevant relationships to disclose
Andrea Richardson
No relevant relationships to disclose
Per Eystein Lonning
No relevant relationships to disclose
Christos Sotiriou
No relevant relationships to disclose
Michael R. Stratton
No relevant relationships to disclose
Peter J. Campbell
No relevant relationships to disclose